LEXICON PHARMACEUTICALS, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| ISHIMOTO LANCE K | SVP, Intellectual Property | Option Exercise | 4,000 | $2.50 | $10,000 | 10,200 | Jun 19, 2007 |
| PIGGOTT JAMES R PHD | SVP of Pharm Bio | Sale | 1,000 | $3.40 | $3,400 | — | May 15, 2007 |
| SANDS ARTHUR T | Pres & CEO | Option Exercise | 300,000 | $1.67 | $501,000 | 872,662 | Mar 29, 2007 |
| ZAMBROWICZ BRIAN P | EVP, Research | Option Exercise | 90,000 | $1.67 | $150,300 | 153,900 | Feb 1, 2007 |
| Mills Barry | — | Purchase | 500 | $3.91 | $1,955 | 1,872 | Aug 18, 2006 |
| SANDS ARTHUR T | Pres & CEO | Sale | 11,690 | $5.10 | $59,619 | 572,662 | Apr 17, 2006 |
| PIGGOTT JAMES R PHD | SVP of Pharm Bio | Sale | 500 | $5.62 | $2,810 | 30,500 | Mar 23, 2006 |
| GREGORY JULIA P | EVP, Corp Dev and CFO | Sale | 7,200 | $3.80 | $27,360 | 50,200 | Dec 30, 2005 |